FRZB and melanoma: Our assumption that SFRP3-mediated inhibition of Wnt5a is the mechanism by which it affects melanoma cell migration, readily explains the relatively small effect of SFRP3 on migration and invasion in A2058 cells with low expression of Wnt5a.